Alnylam Pharma(MX:ALNY)
MX$2,950.000.00 (0.00%)
MX:ALNY
Alnylam Pharma earnings date
MX$2,950.00
At close:0.00 (0.00%)
Alnylam Pharma (ALNY) Q1 2025 Earnings Report
0 Followers
MX:ALNY Q1 2025 EPS Results
- Actual EPS
- -MXN 8.15
- Consensus EPS
- -MXN 16.48
- Beat/Miss
- Beat by +MXN 8.33
- One Year Ago EPS
- -MXN 9.63
MX:ALNY Q1 2025 Revenue Results
- Actual Revenue
- MXN 11.00B
- Expected Revenue
- MXN 10.83B
- Beat/Miss
- Beat by +MXN 167.51M
- YoY Revenue Growth
- +20.20%
Earnings Announcement Details
- Quarter
- Q1 2025
- Date
- 05/01/2025
- Time
- Before Open
- Conference Call
- Thursday, May 1, 2025
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q1 2025 Earnings Call Audio
MX:ALNY Q1 2025 Earnings Call
0:00 / 0:00
Q1 2025 Earnings Slide Deck
Q1 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 31.98- | 15.18 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 30.74291.06 | 34.07 | 754.35% (+256.99) | |
| Jul 30, 2026 | 2026 (Q2) | 30.1822.40 | -9.44 | 337.25% (+31.85) | |
| Apr 30, 2026 | 2026 (Q1) | 16.1527.96 | -8.15 | 443.18% (+36.10) | |
| Feb 12, 2026 | 2025 (Q4) | 21.2915.18 | -12.03 | 226.15% (+27.22) | |
| Oct 30, 2025 | 2025 (Q3) | 10.3934.07 | -16.11 | 311.49% (+50.18) | |
| Jul 31, 2025 | 2025 (Q2) | -10.07-9.44 | -2.41 | -292.31% (-7.04) | |
| May 01, 2025 | 2025 (Q1) | -16.48-8.15 | -9.63 | 15.38% (+1.48) | |
| Feb 13, 2025 | 2024 (Q4) | -10.96-12.03 | -20.37 | 40.91% (+8.33) | |
| Oct 31, 2024 | 2024 (Q3) | -16.98-16.11 | 21.29 | -175.65% (-37.40) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


